Core Viewpoint - GE HealthCare Technologies (GEHC) is currently viewed as a more attractive investment option compared to Stryker (SYK) for value investors, based on stronger earnings outlook and favorable valuation metrics [3][7]. Valuation Metrics - GEHC has a forward P/E ratio of 15.89, significantly lower than SYK's forward P/E of 24.22, indicating that GEHC may be undervalued [5]. - The PEG ratio for GEHC is 1.75, while SYK's PEG ratio stands at 2.11, suggesting that GEHC offers better value relative to its expected earnings growth [5]. - GEHC's P/B ratio is 3.47, compared to SYK's P/B of 6.16, further supporting the notion that GEHC is more attractively priced [6]. Investment Ratings - GEHC holds a Zacks Rank of 2 (Buy), indicating a positive earnings estimate revision trend, while SYK has a Zacks Rank of 3 (Hold) [3]. - Based on the overall valuation metrics, GEHC has a Value grade of A, whereas SYK has a Value grade of C, reinforcing the preference for GEHC among value investors [6].
GEHC or SYK: Which Is the Better Value Stock Right Now?